Accuwell Medics Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.25 Cr
as on 17-11-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.97 Cr
as on 17-11-2024
- Satisfied Charges ₹ 2.44 M
as on 17-11-2024
- Revenue 5.46%
(FY 2023)
- Profit 27.48%
(FY 2023)
- Ebitda 61.56%
(FY 2023)
- Net Worth -0.29%
(FY 2023)
- Total Assets 21.07%
(FY 2023)
About Accuwell Medics
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹3.97 Cr. The company has closed loans amounting to ₹2.44 M, as per Ministry of Corporate Affairs (MCA) records.
Smeet Jain, Mehulkumar Thakkar, and Surubha Solanki serve as directors at the Company.
- CIN/LLPIN
U36109GJ2018PTC104224
- Company No.
104224
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Accuwell Medics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smeet Jain  | Director | 20-Sep-2018 | Current |
| Mehulkumar Thakkar | Director | 13-Mar-2019 | Current |
| Surubha Solanki | Director | 05-Aug-2019 | Current |
Financial Performance of Accuwell Medics.
Accuwell Medics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.46% increase. The company also saw a substantial improvement in profitability, with a 27.48% increase in profit. The company's net worth dipped by a decrease of 0.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accuwell Medics?
Unlock access to Accuwell Medics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Accuwell Healthcare Private LimitedActive 4 years 1 monthSmeet Jain, Mehulkumar Thakkar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Jun 2019 | ₹3.97 Cr | Open |
Others Creation Date: 12 Aug 2022 | ₹1.90 M | Satisfied |
Others Creation Date: 28 May 2021 | ₹0.54 M | Satisfied |
How Many Employees Work at Accuwell Medics?
Unlock and access historical data on people associated with Accuwell Medics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accuwell Medics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accuwell Medics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
